<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK54582" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK54582/" /><meta name="ncbi_pagename" content="Spinocerebellar Ataxia Type 28 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spinocerebellar Ataxia Type 28 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spinocerebellar Ataxia Type 28" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/22" /><meta name="citation_author" content="Alessandro Brussino" /><meta name="citation_author" content="Alfredo Brusco" /><meta name="citation_author" content="Alexandra Durr" /><meta name="citation_author" content="Cecilia Mancini" /><meta name="citation_pmid" content="21595125" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK54582/" /><meta name="citation_keywords" content="SCA28" /><meta name="citation_keywords" content="SCA28" /><meta name="citation_keywords" content="AFG3-like protein 2" /><meta name="citation_keywords" content="AFG3L2" /><meta name="citation_keywords" content="Spinocerebellar Ataxia Type 28" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spinocerebellar Ataxia Type 28" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Alessandro Brussino" /><meta name="DC.Contributor" content="Alfredo Brusco" /><meta name="DC.Contributor" content="Alexandra Durr" /><meta name="DC.Contributor" content="Cecilia Mancini" /><meta name="DC.Date" content="2018/03/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK54582/" /><meta name="description" content="Spinocerebellar ataxia type 28 (SCA28) is characterized by young-adult onset, very slowly progressive gait and limb ataxia resulting in coordination and balance problems, dysarthria, ptosis, nystagmus, and ophthalmoparesis. In most individuals, SCA28 presents as a loss of coordination of lower limbs (unsteadiness, gait ataxia). Less frequently, ptosis/ophthalmoplegia, dysarthria, or upper-limb incoordination may occur as the initial finding. The course of the disease is slowly progressive without impairment of functional autonomy even decades after onset." /><meta name="og:title" content="Spinocerebellar Ataxia Type 28" /><meta name="og:type" content="book" /><meta name="og:description" content="Spinocerebellar ataxia type 28 (SCA28) is characterized by young-adult onset, very slowly progressive gait and limb ataxia resulting in coordination and balance problems, dysarthria, ptosis, nystagmus, and ophthalmoparesis. In most individuals, SCA28 presents as a loss of coordination of lower limbs (unsteadiness, gait ataxia). Less frequently, ptosis/ophthalmoplegia, dysarthria, or upper-limb incoordination may occur as the initial finding. The course of the disease is slowly progressive without impairment of functional autonomy even decades after onset." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK54582/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sca28/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK54582/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A1E91E04140810000000000190008.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK54582_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK54582_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca20/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca36/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK54582_"><span class="title" itemprop="name">Spinocerebellar Ataxia Type 28</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: SCA28</div><p class="contrib-group"><span itemprop="author">Alessandro Brussino</span>, MD, <span itemprop="author">Alfredo Brusco</span>, PhD, <span itemprop="author">Alexandra Durr</span>, MD, PhD, and <span itemprop="author">Cecilia Mancini</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK54582_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK54582_ai__"><div class="contrib half_rhythm"><span itemprop="author">Alessandro Brussino</span>, MD<div class="affiliation small">Department of Medical Sciences<br />University of Turin<br />Turin, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.otinu@onissurb.ordnassela" class="oemail">ti.otinu@onissurb.ordnassela</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alfredo Brusco</span>, PhD<div class="affiliation small">Department of Medical Sciences<br />University of Turin<br />Turin, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.otinu@ocsurb.oderfla" class="oemail">ti.otinu@ocsurb.oderfla</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alexandra Durr</span>, MD, PhD<div class="affiliation small">INSERM U975<br />AP-HP D&#x000e9;partement de G&#x000e9;n&#x000e9;tique<br />Institut du Cerveau et de la Moelle Epini&#x000e8;re<br />Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re University Hospital<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.cmpu@rrud.ardnaxela" class="oemail">rf.cmpu@rrud.ardnaxela</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Cecilia Mancini</span>, PhD<div class="affiliation small">Department of Medical Sciences<br />University of Turin<br />Turin, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.otinu@inicnam.ailicec" class="oemail">ti.otinu@inicnam.ailicec</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 17, 2011</span>; Last Update: <span itemprop="dateModified">March 22, 2018</span>.</p><p><em>Estimated reading time: 17 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sca28.Summary" itemprop="description"><h2 id="_sca28_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spinocerebellar ataxia type 28 (SCA28) is characterized by young-adult onset, very slowly progressive gait and limb ataxia resulting in coordination and balance problems, dysarthria, ptosis, nystagmus, and ophthalmoparesis. In most individuals, SCA28 presents as a loss of coordination of lower limbs (unsteadiness, gait ataxia). Less frequently, ptosis/ophthalmoplegia, dysarthria, or upper-limb incoordination may occur as the initial finding. The course of the disease is slowly progressive without impairment of functional autonomy even decades after onset.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SCA28 is indistinguishable from many other inherited disorders with SCA, the diagnosis of SCA28 is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>AFG3L2</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Ambulatory aids (crutches, canes, walkers); home adaptations as needed; physical therapy to help with tasks such as eating, dressing, walking, and bathing; stretching exercise for those with pyramidal involvement to avoid contractions and lack of comfort during sleep. Speech/ language therapy is helpful for those with dysarthria and swallowing difficulties as is surgery for severe ptosis.</p><p><i>Prevention of secondary complications:</i> Psychological support; weight control to facilitate ambulation; thickened feeds or gastrostomy feedings to avoid aspiration pneumonia.</p><p><i>Surveillance:</i> Annual assessment to evaluate stability or progression of the cerebellar ataxia. Monitoring of speech and swallowing.</p><p><i>Agents/circumstances to avoid:</i> Alcohol consumption and sedatives such as benzodiazepines that may worsen gait ataxia and coordination.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SCA28 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with SCA28 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; the proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown. Each child of an individual with SCA28 has a 50% risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible options if the pathogenic variant in the family has been identified.</p></div></div><div id="sca28.Diagnosis"><h2 id="_sca28_Diagnosis_">Diagnosis</h2><div id="sca28.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Spinocerebellar ataxia type 28 (SCA28) <b>should be suspected in</b> individuals with the following:</p><ul><li class="half_rhythm"><div>Onset generally in young adulthood (but with a wide range: ages 3-76 years)</div></li><li class="half_rhythm"><div>A slowly progressive gait disorder resulting from cerebellar impairment</div></li><li class="half_rhythm"><div>Cerebellar dysarthria</div></li><li class="half_rhythm"><div>Oculomotor abnormalities including ophthalmoparesis, nystagmus and ptosis</div></li><li class="half_rhythm"><div>Hyperreflexia or brisk deep tendon reflexes</div></li><li class="half_rhythm"><div>Brain MRI showing cerebellar atrophy predominantly of the superior vermis, with sparing of the brain stem</div></li><li class="half_rhythm"><div>A family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance</div></li></ul></div><div id="sca28.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SCA28 <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>AFG3L2</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK54582/table/sca28.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figsca28Tmoleculargenetictestingusedi" rid-ob="figobsca28Tmoleculargenetictestingusedi">Table 1</a>).</p><p>Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SCA28 is indistinguishable from many other inherited disorders with SCA, recommended <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> and <b>more comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>AFG3L2,</i> followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended due to a likely <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> or <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> disease mechanism (see <a href="#sca28.Molecular_Genetics">Molecular Genetics</a>).</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>AFG3L2</i> and other genes of interest (see <a href="#sca28.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For this disorder a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is recommended (see <a class="figpopup" href="/books/NBK54582/table/sca28.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figsca28Tmoleculargenetictestingusedi" rid-ob="figobsca28Tmoleculargenetictestingusedi">Table 1</a>). At present the role for whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> in the pathology is not supported by available data. Partial-gene deletions, if identified, would require additional studies to determine clinical significance (see <a href="#sca28.Molecular_Genetics">Molecular Genetics</a>).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="sca28.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in SCA28</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK54582/table/sca28.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca28.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>AFG3L2</i></td><td headers="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;99%&#x000a0;<sup>4,</sup>&#x000a0;<sup>5&#x000a0;,6</sup></td></tr><tr><td headers="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_sca28.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Extremely rare&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sca28.TF.1.1"><p class="no_margin">See <a href="/books/NBK54582/#sca28.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="sca28.TF.1.2"><p class="no_margin">See <a href="#sca28.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="sca28.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="sca28.TF.1.4"><p class="no_margin">Unselected individuals, all exons analyzed [<a class="bk_pop" href="#sca28.REF.cagnoli.2010.1117">Cagnoli et al 2010</a>, <a class="bk_pop" href="#sca28.REF.di_bella.2010.313">Di Bella et al 2010</a>, <a class="bk_pop" href="#sca28.REF.fogel.2014.1237">Fogel et al 2014</a>, <a class="bk_pop" href="#sca28.REF.sawyer.2014.45">Sawyer et al 2014</a>, <a class="bk_pop" href="#sca28.REF.pyle.2015.276">Pyle et al 2015</a>, <a class="bk_pop" href="#sca28.REF.coutelier.2017.1579">Coutelier et al 2017</a>, <a class="bk_pop" href="#sca28.REF.iqbal.2017.e0174667">Iqbal et al 2017</a>]</p></div></dd><dt>5. </dt><dd><div id="sca28.TF.1.5"><p class="no_margin">Autosomal dominant cases, all exons analyzed [<a class="bk_pop" href="#sca28.REF.jia.2012.560">Jia et al 2012</a>, <a class="bk_pop" href="#sca28.REF.n_meth.2013.3106">N&#x000e9;meth et al 2013</a>, <a class="bk_pop" href="#sca28.REF.l_bbe.2014.493">L&#x000f6;bbe et al 2014</a>, <a class="bk_pop" href="#sca28.REF.hadjivassiliou.2017.301">Hadjivassiliou et al 2017</a>, <a class="bk_pop" href="#sca28.REF.szpisjak.2017.979">Szpisjak et al 2017</a>]</p></div></dd><dt>6. </dt><dd><div id="sca28.TF.1.6"><p class="no_margin">Unselected individuals, only exons 15-16 analyzed [<a class="bk_pop" href="#sca28.REF.edener.2010.965">Edener et al 2010</a>, <a class="bk_pop" href="#sca28.REF.musova.2014.331">Musova et al 2014</a>]</p></div></dd><dt>7. </dt><dd><div id="sca28.TF.1.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="sca28.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#sca28.REF.smets.2014.2092">Smets et al [2014]</a> reported a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of exons 14-16, which likely truncates the protein, in two families (likely related) with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> transmission.</p></div></dd></dl></div></div></div></div></div><div id="sca28.Clinical_Characteristics"><h2 id="_sca28_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sca28.Clinical_Description"><h3>Clinical Description</h3><p>Spinocerebellar ataxia type 28 (SCA28) is characterized by young-adult onset, very slowly progressive gait and limb ataxia resulting in coordination and balance problems, dysarthria, ptosis, nystagmus, and ophthalmoparesis.</p><p><b>Age of onset and progression</b>. The usual age at onset is early adulthood (26.5 &#x000b1; 17.2 years); the range is from age three to 78 years. The course of the disorder is slowly progressive without impairment of functional autonomy even decades after onset.</p><p><b>Presentation.</b> In most individuals, SCA28 presents as a loss of coordination of lower limbs (unsteadiness, gait ataxia). Less frequently, ptosis/ophthalmoplegia, dysarthria, or upper-limb incoordination may occur as the initial finding.</p><p><b>Gait and limb ataxia</b></p><ul><li class="half_rhythm"><div>Reflexes may be increased in the lower limbs and Babinski sign is present in some.</div></li><li class="half_rhythm"><div>Decreased vibration sense at the ankles is present in some, but superficial sensation is always normal.</div></li><li class="half_rhythm"><div>Extrapyramidal signs, either parkinsonism (mainly rigidity and/or bradykinesia) or dystonia, have been observed.</div></li></ul><p><b>Dysarthria.</b> Severity can vary from individual to individual and changes with progression of the disorder.</p><ul><li class="half_rhythm"><div>During the initial phases of the disease individuals may have impaired speech, but be easy to understand.</div></li><li class="half_rhythm"><div>Later on, speech becomes slurred so that the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is difficult to understand.</div></li></ul><p><b>Dysphagia.</b> Mild dysphagia has been occasionally reported [<a class="bk_pop" href="#sca28.REF.l_bbe.2014.493">L&#x000f6;bbe et al 2014</a>, <a class="bk_pop" href="#sca28.REF.z_hlke.2015.19">Z&#x000fc;hlke et al 2015</a>, <a class="bk_pop" href="#sca28.REF.szpisjak.2017.979">Szpisjak et al 2017</a>].</p><p><b>Ocular problems</b></p><ul><li class="half_rhythm"><div>Ptosis</div></li><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Ophthalmoparesis with limited horizontal and vertical gaze</div></li></ul><p><b>Intellectual disability, cognitive difficulties, and/or behavior problems</b> have been reported [<a class="bk_pop" href="#sca28.REF.cagnoli.2010.1117">Cagnoli et al 2010</a>, <a class="bk_pop" href="#sca28.REF.edener.2010.965">Edener et al 2010</a>, <a class="bk_pop" href="#sca28.REF.musova.2014.331">Musova et al 2014</a>], but are not considered hallmarks of SCA28. Some individuals have memory and attention deficits [<a class="bk_pop" href="#sca28.REF.szpisjak.2017.979">Szpisjak et al 2017</a>].</p><p><b>Electrophysiologic studies</b>. Some neurogenic changes have been observed in two individuals [<a class="bk_pop" href="#sca28.REF.cagnoli.2010.1117">Cagnoli et al 2010</a>], impaired vibration sense in five [<a class="bk_pop" href="#sca28.REF.z_hlke.2015.19">Z&#x000fc;hlke et al 2015</a>, <a class="bk_pop" href="#sca28.REF.svenstrup.2017.62">Svenstrup et al 2017</a>], impaired thermo- and nociception in two [Z&#x000fc;hlke et al2015], and metatarsal pallanesthesia in one [<a class="bk_pop" href="#sca28.REF.l_bbe.2014.493">L&#x000f6;bbe et al 2014</a>].</p><p><b>Imaging studies.</b> Cerebellar atrophy can be prominent, affecting the vermis with sparing of the brain stem on brain MRI.</p></div><div id="sca28.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> can be proposed based on published studies, although persons with the <a class="figpopup" href="/books/NBK54582/table/sca28.T.afg3l2_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figsca28Tafg3l2pathogenicvariantsdiscu" rid-ob="figobsca28Tafg3l2pathogenicvariantsdiscu">p.Met666Arg</a>, <a class="figpopup" href="/books/NBK54582/table/sca28.T.afg3l2_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figsca28Tafg3l2pathogenicvariantsdiscu" rid-ob="figobsca28Tafg3l2pathogenicvariantsdiscu">p.Glu700Lys</a>, and <a class="figpopup" href="/books/NBK54582/table/sca28.T.afg3l2_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figsca28Tafg3l2pathogenicvariantsdiscu" rid-ob="figobsca28Tafg3l2pathogenicvariantsdiscu">p.Gly671Arg</a> pathogenic variants have early-onset disease (i.e., in infancy/childhood), whereas the other pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are mainly associated with onset in the second to fourth decade [<a class="bk_pop" href="#sca28.REF.mariotti.2008.184">Mariotti et al 2008</a>, <a class="bk_pop" href="#sca28.REF.cagnoli.2010.1117">Cagnoli et al 2010</a>, <a class="bk_pop" href="#sca28.REF.edener.2010.965">Edener et al 2010</a>, <a class="bk_pop" href="#sca28.REF.szpisjak.2017.979">Szpisjak at al 2017</a>].</p></div><div id="sca28.Penetrance"><h3>Penetrance</h3><p>From the studies of SCA28 published to date, disease <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> appears to be complete.</p></div><div id="sca28.Prevalence"><h3>Prevalence</h3><p>According to published data, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>AFG3L2</i> account for approximately 1.5% of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> cerebellar ataxia (ADCA) in individuals of European origin [<a class="bk_pop" href="#sca28.REF.cagnoli.2010.1117">Cagnoli et al 2010</a>, <a class="bk_pop" href="#sca28.REF.di_bella.2010.313">Di Bella et al 2010</a>, <a class="bk_pop" href="#sca28.REF.edener.2010.965">Edener et al 2010</a>], with an estimated incidence of 0.045 in 100,000.</p></div></div><div id="sca28.Genetically_Related_Allelic_Disord"><h2 id="_sca28_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><b>Spastic ataxia 5 (SPAX5)</b> (OMIM <a href="http://omim.org/entry/614487" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614487</a>). The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of two brothers from a <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> relationship, who were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the c.1847A&#x0003e;G (p.Tyr616Cys) sequence variant in <i>AFG3L2</i>, appears to be complex and severe, including spastic gait and epilepsy leading to death of one of the two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> brothers at age 13 years. Mitochondrial DNA depletion was also noted [<a class="bk_pop" href="#sca28.REF.pierson.2011.e1002325">Pierson et al 2011</a>]. It is not clear if the phenotype results from the sequence variant in <i>AFG3L2</i> alone or from pathogenic variants in another <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes as well. An additional report by <a class="bk_pop" href="#sca28.REF.muona.2015.39">Muona et al [2015]</a> described two unrelated individuals with a different homozygous <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant and a less severe phenotype than those reported by <a class="bk_pop" href="#sca28.REF.pierson.2011.e1002325">Pierson et al [2011]</a>. The variants associated with SPAX5 occur outside the region common for SCA28-causing variants.</p></div><div id="sca28.Differential_Diagnosis"><h2 id="_sca28_Differential_Diagnosis_">Differential Diagnosis</h2><p>The ataxic gait of persons with SCA28 is indistinguishable from that seen in other adult-onset inherited or acquired ataxias. When the family history suggests <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance, all other autosomal dominant cerebellar ataxias (ADCAs) have to be considered (see <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>).</p><ul><li class="half_rhythm"><div>The most commonly occurring SCAs, those caused by polyglutamine expansions (i.e., <a href="/books/n/gene/sca1/">SCA1</a>, <a href="/books/n/gene/sca2/">SCA2</a>, <a href="/books/n/gene/sca3/">SCA3</a>, <a href="/books/n/gene/sca7/">SCA7</a>, <a href="/books/n/gene/sca17/">SCA17</a> and <a href="/books/n/gene/drpla/">DRPLA</a>), usually begin before age 30 years, are more rapidly progressive, and have brain stem involvement on MRI.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sca6/">SCA6</a> is characterized by adult-onset slowly progressive ataxia and gaze-evoked nystagmus findings that overlap with those of SCA28.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/spg7/">SPG7</a> is characterized by adult-onset slowly progressive ataxia with increased reflexes (or even spasticity), ophthalmoparesis, and optic atrophy.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/friedreich/">Friedreich ataxia</a> and <a href="/books/n/gene/aoa/">ataxia with oculomotor apraxia type 1</a> and <a href="/books/n/gene/aoa2/">type 2</a> (AOA1 and AOA2) are <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and more rapidly progressive than SCA28, and usually have childhood onset and severe peripheral involvement (polyneuropathy).</div></li></ul><p>Mitochondrial disorders, especially those associated with external ophthalmoplegia and ptosis, should be considered as well (see <a href="/books/n/gene/kss/">Mitochondrial DNA Deletion Syndromes</a> and <a href="/books/n/gene/mt-overview/">Mitochondrial Disorders Overview</a>).</p></div><div id="sca28.Management"><h2 id="_sca28_Management_">Management</h2><div id="sca28.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with spinocerebellar ataxia type 28 (SCA28) the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div class="half_rhythm">Neurologic examination (including scales to evaluate the severity of cerebellar ataxia and to allow subjective follow up)</div></li><li class="half_rhythm"><div class="half_rhythm">Cerebral MRI</div><div class="half_rhythm">Note: MRI is part of the routine evaluation of persons with ataxia; however, in SCA28 no association between the extent of cerebellar atrophy and disease severity or progression has been proven.</div></li><li class="half_rhythm"><div class="half_rhythm">Speech assessment and evaluation for swallowing difficulties</div></li><li class="half_rhythm"><div class="half_rhythm">Examination by an ophthalmologist</div></li><li class="half_rhythm"><div class="half_rhythm">Evaluation of cognitive abilities</div></li><li class="half_rhythm"><div class="half_rhythm">Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sca28.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>At present, only symptomatic treatments are available. These include the following:</p><ul><li class="half_rhythm"><div>Crutches (less often canes) and walkers</div></li><li class="half_rhythm"><div>Home adaptations including grab bars for the bathtub or shower chairs and raised toilet seats as needed</div></li><li class="half_rhythm"><div>Physical therapy to ameliorate coordination difficulties, especially with tasks such as eating, dressing, walking, and bathing</div></li><li class="half_rhythm"><div>Stretching exercise for those with pyramidal involvement to avoid contractions and lack of comfort during sleep</div></li><li class="half_rhythm"><div>Speech/language therapy for dysarthria and swallowing difficulties</div></li><li class="half_rhythm"><div>Surgical intervention as needed for severe ptosis</div></li></ul></div><div id="sca28.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Psychological support helps <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals cope with the consequences of the disease.</p><p>Weight control can facilitate ambulation.</p><p>To avoid complications such as aspiration pneumonia, thickened feeds or gastrostomy should be considered.</p></div><div id="sca28.Surveillance"><h3>Surveillance</h3><p>Annual assessment of the cerebellar ataxia using SARA (Scale for the Assessment and Rating of Cerebellar Ataxia), CCFS (Composite Cerebellar Functional Severity Score), or similar scales should be performed to evaluate stability or progression of the disease.</p><p>Monitoring of speech and swallowing difficulties is recommended.</p></div><div id="sca28.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Alcohol consumption and sedatives such as benzodiazepines may worsen gait ataxia and coordination difficulties.</p></div><div id="sca28.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sca28.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sca28.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://www.ClinicalTrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="sca28.Genetic_Counseling"><h2 id="_sca28_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sca28.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spinocerebellar ataxia type 28 (SCA28) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="sca28.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with SCA28 have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with SCA28 may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown.</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with SCA28 may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the pathogenic variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband&#x02019;s parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>If the parents have been tested for the <i>AFG3L2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and:</div><ul><li class="half_rhythm"><div>A parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>AFG3L2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%. The intrafamilial phenotypic variability reported among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals is usually related to onset age or disease duration.</div></li><li class="half_rhythm"><div>The <i>AFG3L2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic risk of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>AFG3L2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. The sibs of a proband with clinically unaffected parents are still at increased risk for SCA28 because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent or the theoretic risk of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with SCA28 is at 50% risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>AFG3L2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="sca28.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder it is likely that the proband has the disorder as a result of a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Testing of at-risk asymptomatic adults.</b> Testing of at-risk asymptomatic adults for SCA28 is possible using the techniques described in <a href="#sca28.Establishing_the_Diagnosis">Molecular Genetic Testing</a>. Such testing is not useful in accurately predicting age of onset, disease severity, type of symptoms, or rate of progression in asymptomatic individuals. When testing at-risk individuals for SCA28 an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member should be tested first to confirm the molecular diagnosis in the family.</p><p>Testing for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the absence of definite symptoms of the disease is predictive testing. At-risk asymptomatic adult family members may seek testing in order to make personal decisions regarding reproduction, financial matters, and career planning. Others may have different motivations including simply the "need to know." Testing of asymptomatic at-risk adult family members should involve pre-test interviews in which the motives for requesting the test, the individual's knowledge of SCA28, the possible impact of positive and negative test results, and neurologic status are assessed. Those seeking testing should be counseled about possible problems that they may encounter with regard to health, life, and disability insurance coverage, employment and educational discrimination, and changes in social and family interaction. Other issues to consider are implications for the at-risk status of other family members. Informed consent should be procured and records kept confidential. Individuals with a positive test result need arrangements for long-term follow-up and evaluations.</p><p><b>Molecular genetic testing of asymptomatic individuals younger than age 18 years</b> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p><p>For more information, see also the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sca28.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>AFG3L2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="sca28.Resources"><h2 id="_sca28_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22234/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spinocerebellar ataxia</a></div></li><li class="half_rhythm"><div><b>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</b></div><div><i>Booklet providing information about Spinocerebellar Ataxia</i></div><div><a href="http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf</a></div></li><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>Spanish Ataxia Federation (FEDAES)</b></div><div>Spain</div><div><b>Phone:</b> 34 983 278 029; 34 985 097 152; 34 634 597 503</div><div><b>Email:</b> sede.valladolid@fedaes.org; sede.gijon@fedaes.org; sede.bilbao@fedaes.org</div><div><a href="http://www.fedaes.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fedaes.org</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="sca28.Molecular_Genetics"><h2 id="_sca28_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sca28.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spinocerebellar Ataxia Type 28: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK54582/table/sca28.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca28.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sca28.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sca28.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sca28.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sca28.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_sca28.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sca28.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sca28.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/10939" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>AFG3L2</i></a></td><td headers="hd_b_sca28.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=10939" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">18p11<wbr style="display:inline-block"></wbr>​.21</a></td><td headers="hd_b_sca28.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9Y4W6" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AFG3-like protein 2</a></td><td headers="hd_b_sca28.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/AFG3L2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AFG3L2 database</a></td><td headers="hd_b_sca28.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=AFG3L2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AFG3L2</a></td><td headers="hd_b_sca28.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=AFG3L2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">AFG3L2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sca28.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sca28.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spinocerebellar Ataxia Type 28 (<a href="/omim/604581,610246" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK54582/table/sca28.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca28.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/604581" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">604581</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATPase FAMILY GENE 3-LIKE 2; AFG3L2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610246" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610246</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA 28; SCA28</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>AFG3L2</i> has 17 coding exons and spans ~48 kb on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 18p11.21. There is a single disease-relevant transcript encoding for a 797-amino acid protein. The 3&#x02019;UTR of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> partially overlaps the 5&#x02019;UTR of a <i>TUBB6</i> <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> isoform.</p><p><b>Pathogenic variants.</b> All known pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants or small <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a>/<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> variants.</p><p>Variants predicted to be <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> should be interpreted cautiously, and referred as pathogenic only if supported by functional studies. For example, a potential loss-of-function variant in one case results in a truncated protein being produced, suggesting a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> mechanism [Smets et al 2014&#x000fc;&#x000fc;]. However, in a second case a c.1958dupT variant was passed from an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> mother to her unaffected daughter, strongly suggesting that the variant is not associated with disease [<a class="bk_pop" href="#sca28.REF.musova.2014.331">Musova et al 2014</a>].</p><div id="sca28.T.afg3l2_pathogenic_variants_discu" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>AFG3L2</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK54582/table/sca28.T.afg3l2_pathogenic_variants_discu/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca28.T.afg3l2_pathogenic_variants_discu_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1295A&#x0003e;C</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn432Thr</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_006796.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_006796<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_006787.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_006787<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1958dupT</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr654AsnfsTer15</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1996A&#x0003e;G</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met666Val</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1997T&#x0003e;G</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met666Arg</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1997T&#x0003e;C</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met666Thr</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2011G&#x0003e;A</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly671Arg</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2012G&#x0003e;A</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly671Glu</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2062C&#x0003e;A</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro688Thr</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2065T&#x0003e;A</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr689Asn</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2065T&#x0003e;C</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr689His</td></tr><tr><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2098G&#x0003e;A</td><td headers="hd_h_sca28.T.afg3l2_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu700Lys</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>AFG3L2</i> encodes an ATP-dependent metalloprotease belonging to the AAA-superfamily (<i>A</i>TPases <i>a</i>ssociated with a variety of cellular activities). This gene was cloned as a paralog of <i>SPG7</i> (paraplegin) [<a class="bk_pop" href="#sca28.REF.banfi.1999.51">Banfi et al 1999</a>], whose <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> inactivation causes an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of hereditary spastic paraplegia (HSP) [<a class="bk_pop" href="#sca28.REF.casari.1998.973">Casari et al 1998</a>] (see <a href="/books/n/gene/spg7/">Spastic Paraplegia 7</a>).</p><p>Both AFG3L2 and paraplegin are mitochondrial proteins, and are highly conserved through evolution &#x02013; the orthologous protein FtsH being present in <i>E</i>
<i>coli</i> [<a class="bk_pop" href="#sca28.REF.ito.2005.211">Ito &#x00026; Akiyama 2005</a>].</p><p>The two proteins have been extensively studied in yeast models (orthologous genes are <i>Yta10</i> (<i>SPG7</i>) and <i>Yta12</i> (<i>AFG3L2</i>). Yta10p-12p constitutes a membrane-embedded complex of ~850 kd (m-AAA protease), active on the matrix side of the inner mitochondrial membrane (IMM) [<a class="bk_pop" href="#sca28.REF.arlt.1996.875">Arlt et al 1996</a>, <a class="bk_pop" href="#sca28.REF.arlt.1998.4837">Arlt et al 1998</a>].</p><p>Studies in yeast assigned a dual activity to the m-AAA protease for protein degradation and activation (cleavage) [<a class="bk_pop" href="#sca28.REF.nolden.2005.277">Nolden et al 2005</a>]:</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">It conducts protein quality surveillance in the IMM and degrades non-assembled membrane proteins to peptides [<a class="bk_pop" href="#sca28.REF.arlt.1996.875">Arlt et al 1996</a>, <a class="bk_pop" href="#sca28.REF.leonhard.2000.629">Leonhard et al 2000</a>];</p></dd><dt>2.</dt><dd><p class="no_top_margin">It mediates protein processing and thereby activates certain mitochondrial proteins [<a class="bk_pop" href="#sca28.REF.koppen.2009.4216">Koppen et al 2009</a>].</p></dd></dl><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Except for one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (c.1295A&#x0003e;C; p.Asn432Thr), all known pathogenic variants are located in the M41-protease <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the AFG3L2 protein [<a class="bk_pop" href="#sca28.REF.cagnoli.2010.1117">Cagnoli et al 2010</a>, <a class="bk_pop" href="#sca28.REF.di_bella.2010.313">Di Bella et al 2010</a>, <a class="bk_pop" href="#sca28.REF.edener.2010.965">Edener et al 2010</a>].</p><p>The clustering of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in a narrow region of the protein suggests the presence of a critical functional <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Several pathogenic variants occur on the same three codons: p.Met666, p.Gly671, and p.Tyr689. Data extracted from ExAC and gnomAD metrics include <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants reported in the population (<a href="http://exac.broadinstitute.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">exac.broadinstitute.org</a>; <a href="http://gnomad.broadinstitute.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">gnomad.broadinstitute.org</a>) [<a class="bk_pop" href="#sca28.REF.lek.2016.285">Lek et al 2016</a>]. Of note, 66 control subjects (~1:1,800) are reported in gnomAD data with frameshift/stop-gain/<a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants/<a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> deletions.</p><p>Overall these data strongly indicate that haplosufficient alleles occur in the population, and that <i>AFG3L2</i> variants causative of SCA28 act through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> or <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> mechanism.</p><p>Yta10-Yta12-deficient yeast cells fail to be complemented by expression of mutated human AFG3L2 protein [<a class="bk_pop" href="#sca28.REF.di_bella.2010.313">Di Bella et al 2010</a>].</p></div><div id="sca28.References"><h2 id="_sca28_References_">References</h2><div id="sca28.Published_Guidelines__Consensus_St"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca28.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 3-15-18. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2017. Accessed 3-15-18.</div></li></ul></div><div id="sca28.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.arlt.1998.4837">Arlt H, Steglich G, Perryman R, Guiard B, Neupert W, Langer T. The formation of respiratory chain complexes in mitochondria is under the proteolytic control of the m-AAA protease. <span><span class="ref-journal">EMBO J. </span>1998;<span class="ref-vol">17</span>:4837–47.</span> [<a href="/pmc/articles/PMC1170813/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1170813</span></a>] [<a href="/pubmed/9707443" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9707443</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.arlt.1996.875">Arlt H, Tauer R, Feldmann H, Neupert W, Langer T. The YTA10-12 complex, an AAA protease with chaperone-like activity in the inner membrane of mitochondria. <span><span class="ref-journal">Cell. </span>1996;<span class="ref-vol">85</span>:875–85.</span> [<a href="/pubmed/8681382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8681382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.banfi.1999.51">Banfi S, Bassi MT, Andolfi G, Marchitiello A, Zanotta S, Ballabio A, Casari G, Franco B. Identification and characterization of AFG3L2, a novel paraplegin-related gene. <span><span class="ref-journal">Genomics. </span>1999;<span class="ref-vol">59</span>:51–8.</span> [<a href="/pubmed/10395799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10395799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.cagnoli.2010.1117">Cagnoli C, Stevanin G, Brussino A, Barberis M, Mancini C, Margolis RL, Holmes SE, Nobili M, Forlani S, Padovan S, Pappi P, Zaros C, Leber I, Ribai P, Pugliese L, Assalto C, Brice A, Migone N, D&#x000fc;rr A, Brusco A. Missense mutations in the AFG3L2 proteolytic domain account for ~1.5% of European autosomal dominant cerebellar ataxias. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:1117–24.</span> [<a href="/pubmed/20725928" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20725928</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.casari.1998.973">Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, D&#x000fc;rr A, Fontaine B, Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. <span><span class="ref-journal">Cell. </span>1998;<span class="ref-vol">93</span>:973–83.</span> [<a href="/pubmed/9635427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9635427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.coutelier.2017.1579">Coutelier M, Coarelli G, Monin ML, Konop J, Davoine CS, Tesson C, Valter R, Anheim M, Behin A, Castelnovo G, Charles P, David A, Ewenczyk C, Fradin M, Goizet C, Hannequin D, Labauge P, Riant F, Sarda P, Sznajer Y, Tison F, Ullmann U, Van Maldergem L, Mochel F, Brice A, Stevanin G, Durr A. SPATAX network. A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies. <span><span class="ref-journal">Brain. </span>2017;<span class="ref-vol">140</span>:1579–94.</span> [<a href="/pubmed/28444220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28444220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.di_bella.2010.313">Di Bella D, Lazzaro F, Brusco A, Plumari M, Battaglia G, Pastore A, Finardi A, Cagnoli C, Tempia F, Frontali M, Veneziano L, Sacco T, Boda E, Brussino A, Bonn F, Castellotti B, Baratta S, Mariotti C, Gellera C, Fracasso V, Magri S, Langer T, Plevani P, Di Donato S, Muzi-Falconi M, Taroni F. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:313–21.</span> [<a href="/pubmed/20208537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20208537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.edener.2010.965">Edener U, W&#x000f6;llner J, Hehr U, Kohl Z, Schilling S, Kreuz F, Bauer P, Bernard V, Gillessen-Kaesbach G, Z&#x000fc;hlke C. Early onset and slow progression of SCA28, a rare dominant ataxia in a large four-generation family with a novel AFG3L2 mutation. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;2010;<span class="ref-vol">18</span>:965–8.</span> [<a href="/pmc/articles/PMC2987378/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987378</span></a>] [<a href="/pubmed/20354562" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20354562</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.fogel.2014.1237">Fogel BL, Lee H, Deignan JL, Strom SP, Kantarci S, Wang X, Quintero-Rivera F, Vilain E, Grody WW, Perlman S, Geschwind DH, Nelson SF. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. <span><span class="ref-journal">JAMA Neurol. </span>2014;<span class="ref-vol">71</span>:1237–46.</span> [<a href="/pmc/articles/PMC4324730/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4324730</span></a>] [<a href="/pubmed/25133958" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25133958</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.hadjivassiliou.2017.301">Hadjivassiliou M, Martindale J, Shanmugarajah P, Gr&#x000fc;newald RA, Sarrigiannis PG, Beauchamp N, Garrard K, Warburton R, Sanders DS, Friend D, Duty S, Taylor J, Hoggard N. Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2017;<span class="ref-vol">88</span>:301–9.</span> [<a href="/pubmed/27965395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27965395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.iqbal.2017.e0174667">Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstr&#x000f8;m L, Rengmark AH, Henriksen SP, Tallaksen CM, Toft M. Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia. <span><span class="ref-journal">PLoS One. </span>2017;<span class="ref-vol">12</span>:e0174667.</span> [<a href="/pmc/articles/PMC5375131/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5375131</span></a>] [<a href="/pubmed/28362824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28362824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.ito.2005.211">Ito K, Akiyama Y. Cellular functions, mechanism of action, and regulation of FtsH protease. <span><span class="ref-journal">Annu Rev Microbiol. </span>2005;<span class="ref-vol">59</span>:211–31.</span> [<a href="/pubmed/15910274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15910274</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.jia.2012.560">Jia D, Tang B, Chen Z, Shi Y, Sun Z, Zhang L, Wang J, Xia K, Jiang H. Spinocerebellar ataxia type 28 (SCA28) is an uncommon cause of dominant ataxia among Chinese kindreds. <span><span class="ref-journal">Int J Neurosci. </span>2012;<span class="ref-vol">122</span>:560–2.</span> [<a href="/pubmed/22563911" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22563911</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.koppen.2009.4216">Koppen M, Bonn F, Ehses S, Langer T. Autocatalytic processing of m-AAA protease subunits in mitochondria. <span><span class="ref-journal">Mol Biol Cell. </span>2009;<span class="ref-vol">20</span>:4216–24.</span> [<a href="/pmc/articles/PMC2754935/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2754935</span></a>] [<a href="/pubmed/19656850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19656850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.lek.2016.285">Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al.  Analysis of protein-coding genetic variation in 60,706 humans. <span><span class="ref-journal">Nature. </span>2016;<span class="ref-vol">536</span>:285–91.</span> [<a href="/pmc/articles/PMC5018207/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5018207</span></a>] [<a href="/pubmed/27535533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27535533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.leonhard.2000.629">Leonhard K, Guiard B, Pellecchia G, Tzagoloff A, Neupert W, Langer T. Membrane protein degradation by AAA proteases in mitochondria: extraction of substrates from either membrane surface. <span><span class="ref-journal">Mol Cell. </span>2000;<span class="ref-vol">5</span>:629–38.</span> [<a href="/pubmed/10882099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10882099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.l_bbe.2014.493">L&#x000f6;bbe AM, Kang JS, Hilker R, Hackstein H, M&#x000fc;ller U, Nolte D. A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28. <span><span class="ref-journal">J Mol Neurosci. </span>2014;<span class="ref-vol">52</span>:493–6.</span> [<a href="/pubmed/24293060" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24293060</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.mariotti.2008.184">Mariotti C, Brusco A, Di Bella D, Cagnoli C, Seri M, Gellera C, Di Donato S, Taroni F. Spinocerebellar ataxia type 28: a novel autosomal dominant cerebellar ataxia characterized by slow progression and ophthalmoparesis. <span><span class="ref-journal">Cerebellum. </span>2008;<span class="ref-vol">7</span>:184–8.</span> [<a href="/pubmed/18769991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18769991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.muona.2015.39">Muona M, Berkovic SF, Dibbens LM, Oliver KL, Maljevic S, Bayly MA, Joensuu T, Canafoglia L, Franceschetti S, Michelucci R, Markkinen S, Heron SE, Hildebrand MS, Andermann E, Andermann F, Gambardella A, Tinuper P, Licchetta L, Scheffer IE, Criscuolo C, Filla A, Ferlazzo E, Ahmad J, Ahmad A, Baykan B, Said E, Topcu M, Riguzzi P, King MD, Ozkara C, Andrade DM, Engelsen BA, Crespel A, Lindenau M, Lohmann E, Saletti V, Massano J, Privitera M, Espay AJ, Kauffmann B, Duchowny M, M&#x000f8;ller RS, Straussberg R, Afawi Z, Ben-Zeev B, Samocha KE, Daly MJ, Petrou S, Lerche H, Palotie A, Lehesjoki AE. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy. <span><span class="ref-journal">Nat Genet. </span>2015;<span class="ref-vol">47</span>:39–46.</span> [<a href="/pmc/articles/PMC4281260/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4281260</span></a>] [<a href="/pubmed/25401298" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25401298</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.musova.2014.331">Musova Z, Kaiserova M, Kriegova E, Fillerova R, Vasovcak P, Santava A, Mensikova K, Zumrova A, Krepelova A, Sedlacek Z, Kanovsky P. A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia. <span><span class="ref-journal">Cerebellum. </span>2014;<span class="ref-vol">13</span>:331–7.</span> [<a href="/pubmed/24272953" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24272953</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.n_meth.2013.3106">N&#x000e9;meth AH, Kwasniewska AC, Lise S, Parolin Schnekenberg R, Becker EB, Bera KD, Shanks ME, Gregory L, Buck D, Zameel Cader M, Talbot K, de Silva R, Fletcher N, Hastings R, Jayawant S, Morrison PJ, Worth P, Taylor M, Tolmie J, O'Regan M., UK Ataxia Consortium.  Valentine R, Packham E, Evans J, Seller A, Ragoussis J. Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:3106–18.</span> [<a href="/pmc/articles/PMC3784284/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3784284</span></a>] [<a href="/pubmed/24030952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24030952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.nolden.2005.277">Nolden M, Ehses S, Koppen M, Bernacchia A, Rugarli EI, Langer T. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. <span><span class="ref-journal">Cell. </span>2005;<span class="ref-vol">123</span>:277–89.</span> [<a href="/pubmed/16239145" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16239145</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.pierson.2011.e1002325">Pierson TM, Adams D, Bonn F, Martinelli P, Cherukuri PF, Teer JK, Hansen NF, Cruz P. Mullikin For The Nisc Comparative Sequencing Program JC, Blakesley RW, Golas G, Kwan J, Sandler A, Fuentes Fajardo K, Markello T, Tifft C, Blackstone C, Rugarli EI, Langer T, Gahl WA, Toro C. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases. <span><span class="ref-journal">PLoS Genet. </span>2011;<span class="ref-vol">7</span>:e1002325.</span> [<a href="/pmc/articles/PMC3192828/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3192828</span></a>] [<a href="/pubmed/22022284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22022284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.pyle.2015.276">Pyle A, Smertenko T, Bargiela D, Griffin H, Duff J, Appleton M, Douroudis K, Pfeffer G, Santibanez-Koref M, Eglon G, Yu-Wai-Man P, Ramesh V, Horvath R, Chinnery PF. Exome sequencing in undiagnosed inherited and sporadic ataxias. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:276–83.</span> [<a href="/pmc/articles/PMC4306819/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4306819</span></a>] [<a href="/pubmed/25497598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25497598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.sawyer.2014.45">Sawyer SL, Schwartzentruber J, Beaulieu CL, Dyment D, Smith A, Warman Chardon J, Yoon G, Rouleau GA, Suchowersky O, Siu V, Murphy L, Hegele RA, Marshall CR., FORGE Canada Consortium.  Bulman DE, Majewski J, Tarnopolsky M, Boycott KM. Exome sequencing as a diagnostic tool for pediatric-onset ataxia. <span><span class="ref-journal">Hum Mutat. </span>2014;<span class="ref-vol">35</span>:45–9.</span> [<a href="/pmc/articles/PMC4255313/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4255313</span></a>] [<a href="/pubmed/24108619" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24108619</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.smets.2014.2092">Smets K, Deconinck T, Baets J, Sieben A, Martin JJ, Smouts I, Wang S, Taroni F, Di Bella D, Van Hecke W, Parizel PM, Jadoul C, De Potter R, Couvreur F, Rugarli E, De Jonghe P. Partial deletion of AFG3L2 causing spinocerebellar ataxia type 28. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:2092–100.</span> [<a href="/pubmed/24814845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24814845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.svenstrup.2017.62">Svenstrup K, Nielsen TT, Aidt F, Rostgaard N, Duno M, Wibrand F, Vinther-Jensen T, Law I, Vissing J, Roos P, Hjermind LE, Nielsen JE. SCA28: novel mutation in the AFG3L2 proteolytic domain causes a mild cerebellar syndrome with selective type-1 muscle fiber atrophy. <span><span class="ref-journal">Cerebellum. </span>2017;<span class="ref-vol">16</span>:62–7.</span> [<a href="/pubmed/26868664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26868664</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.szpisjak.2017.979">Szpisjak L, Nemeth VL, Szepfalusi N, Zadori D, Maroti Z, Kalmar T, Vecsei L, Klivenyi P. Neurocognitive characterization of an SCA28 family caused by a novel AFG3L2 gene mutation. <span><span class="ref-journal">Cerebellum. </span>2017;<span class="ref-vol">16</span>:979–85.</span> [<a href="/pubmed/28660440" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28660440</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.z_hlke.2015.19">Z&#x000fc;hlke C, Mikat B, Timmann D, Wieczorek D, Gillessen-Kaesbach G, B&#x000fc;rk K. Spinocerebellar ataxia 28: a novel AFG3L2 mutation in a German family with young onset, slow progression and saccadic slowing. <span><span class="ref-journal">Cerebellum Ataxias. </span>2015;<span class="ref-vol">2</span>:19.</span> [<a href="/pmc/articles/PMC4681123/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4681123</span></a>] [<a href="/pubmed/26677414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26677414</span></a>]</div></li></ul></div><div id="sca28.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.brice.2005.98">Brice G, Child AH, Evans A, Bell R, Mansour S, Burnand K, Sarfarazi M, Jeffery S, Mortimer P. Milroy disease and the VEGFR-3 mutation phenotype. <span><span class="ref-journal">J Med Genet. </span>2005;<span class="ref-vol">42</span>:98–102.</span> [<a href="/pmc/articles/PMC1735984/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735984</span></a>] [<a href="/pubmed/15689446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15689446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.lichtenstein.2001">Lichtenstein L, Kaplan L. Alkaptonuria and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. Vol 2. 8 ed. New York, NY: McGraw-Hill; 2001:2109-23.</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.muntoni.2004.79">Muntoni F. Journey into muscular dystrophies caused by abnormal glycosylation. <span><span class="ref-journal">Acta Myol. </span>2004;<span class="ref-vol">23</span>:79–84.</span> [<a href="/pubmed/15605948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15605948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca28.REF.wolfsdorf.2003.95">Wolfsdorf JI, Weinstein DA. Glycogen storage diseases. <span><span class="ref-journal">Rev Endocr Metab Disord. </span>2003;<span class="ref-vol">4</span>:95–102.</span> [<a href="/pubmed/12618563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12618563</span></a>]</div></li></ul></div></div><div id="sca28.Chapter_Notes"><h2 id="_sca28_Chapter_Notes_">Chapter Notes</h2><div id="sca28.Acknowledgments"><h3>Acknowledgments</h3><p>Telethon Foundation support is gratefully acknowledged (grant GGP07110)</p></div><div id="sca28.Revision_History"><h3>Revision History</h3><p>&#x02022; 22 March 2018 (ha) Comprehensive update posted live</p><p>&#x02022; 7 February 2013 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available</p><p>&#x02022; 17 May 2011 (me) Review posted live</p><p>&#x02022; 7 February 2011 (ab) Original submission</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK54582</span><span class="label">PMID: <a href="/pubmed/21595125" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21595125</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca20/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca36/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK54582&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK54582/?report=reader">PubReader</a></li><li><a href="/books/NBK54582/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK54582" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK54582" style="display:none" title="Cite this Page"><div class="bk_tt">Brussino A, Brusco A, Durr A, et al. Spinocerebellar Ataxia Type 28. 2011 May 17 [Updated 2018 Mar 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK54582/pdf/Bookshelf_NBK54582.pdf">PDF version of this page</a> (437K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sca28.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sca28.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sca28.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sca28.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sca28.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sca28.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sca28.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sca28.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sca28.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sca28.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sca28.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=10939[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">AFG3L2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK54582+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2467242" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2467242" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2467242" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2467242" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31294938" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 38</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 38<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brusco A, Di Gregorio E, Borroni B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301319" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 6</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 6<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Casey HL, Gomez CM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301354" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 10</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 10<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Matsuura T, Ashizawa T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301573" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 14</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 14<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen DH, Bird TD, Raskind WH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21595125" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21595125" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04144075f66d18aa16a6f4">Spinocerebellar Ataxia Type 28 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spinocerebellar Ataxia Type 28 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:00:32-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A1E91E04140810000000000190008&amp;ncbi_session=CE8A1E91E04143F1_0025SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK54582%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK54582&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK54582/&amp;ncbi_pagename=Spinocerebellar Ataxia Type 28 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A1E91E04143F1_0025SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>